Detection and Classification of Cardiac Rhythm and Atrial Fibrillation Using a Finger-worn Ring

Everbeat is a finger-worn ring that has a built-in electrocardiogram (ECG). In this study the investigators ensure that the ECG as read by the everbeat correctly classifies heart rhythms and detects atrial fibrillation. Investigators will also correlate the everbeat ECG waveform with a clinical-grade FDA approved electrocardiogram to ensure it may be reliably interpreted by clinicians or other algorithms.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Key information

Conditions

Atrial Fibrillation (AF) Arrhythmias Cardiac Arrhythmias, Cardiac Atrial Fibrillation Bradycardia Cardiac Conduction System Disease Cardiovascular Diseases Heart Diseases Palpitations Pathologic Processes Pathological Conditions, Signs and Symptoms Tachycardia

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

XIMED, La Jolla, California, United States

About this study

In this study the participant will obtain a simultaneous electrocardiogram from both the everbeat ring system and a clinical-grade diagnostic ECG machine for correlation and analysis.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

18 years of age or older

Exclusion criteria

Presence of pacemaker or defibrillator
Inability to wear a ring in size range available

Treatment and study plan

Atrial Fibrillation Identification

Diagnostic Test

Identification of atrial fibrillation by device.

Primary outcomes

Rhythm classification

Time frame: Baseline

Automated rhythm characterization by the ring device as normal sinus rhythm, atrial fibrillation or other.

Sponsors and collaborators

Lead sponsor

Everbeat

Industry

Registry information

Official study title

Finger Worn Detection Via Electrocardiographic Ring of Atrial Fibrillation and ECG Waveform Analysis (FINDER-AF)

Acronym: FINDER-AF

Important dates

Study start: 2024
Primary completion: 2025
Study completion: 2025
First posted: Mar 25, 2025
Registry last updated: Mar 27, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Recruiting